Project Details
Description
Phase II Study of Pembrolizumab in the Immunoreactive Ovarian Cancer Subtype
| Status | Finished |
|---|---|
| Effective start/end date | 3/6/19 → 3/30/24 |
Funding
- UNIVERSITY OF CALIFORNIA, LOS ANGEL
- MERCK
Phase II Study of Pembrolizumab in the Immunoreactive Ovarian Cancer Subtype
- Winterhoff, Boris J (PI)
Project: Research project